First PROTAC wins FDA approval. This one targets certain metastatic breast cancers.
This is the first of a totally new type of drug that is set to revolutionize drug development.
The story of PROTACs is fascinating and a testament to fundamental research.
It starts with two lines of research including research one why thalidomide causes birth defects the other on how to harness cellular machinery for therapeutics.
1/馃У
